An Exciting Option for Critical Care Teams
The Seraph 100 uses microbead adsorption media with chemically-bonded heparin to mimic the binding sites that COVID-19 uses when they invade the bloodstream. COVID-19 is removed from the bloodstream, and once bound, remains in the filter.
Patients Tell Their Stories
Extracorporeal—meaning outside the body—blood purification treatments are usually reserved for the severely or critically ill patient. Learn more about how Seraph 100 is used to treat COVID-19.
In the News
See what’s happening at ExThera Medical and recent updates about the Seraph 100 and ONCObind.
Seraph 100 Blood Filtration Media May Reduce Tumor-Associated Particles in Blood Samples Drawn From Pancreatic Cancer Patients
ExThera Medical Receives MTEC Award for Pivotal Sepsis Trial
ExThera Announces Completion of Phase I OSCAR I Trial
Revolutionary Trial Aims to Transform Pancreatic Cancer Treatment
MM00017 Rev E